nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP1A2—Estropipate—osteoporosis	0.056	0.102	CbGbCtD
Irbesartan—CYP2C9—Estropipate—osteoporosis	0.0505	0.0916	CbGbCtD
Irbesartan—CYP2C8—Raloxifene—osteoporosis	0.0483	0.0876	CbGbCtD
Irbesartan—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0467	0.0846	CbGbCtD
Irbesartan—CYP2C8—Cholecalciferol—osteoporosis	0.0373	0.0677	CbGbCtD
Irbesartan—CYP2C8—Estradiol—osteoporosis	0.0301	0.0545	CbGbCtD
Irbesartan—CYP3A4—Estropipate—osteoporosis	0.0294	0.0533	CbGbCtD
Irbesartan—CYP3A4—Calcitriol—osteoporosis	0.0294	0.0533	CbGbCtD
Irbesartan—CYP1A2—Conjugated Estrogens—osteoporosis	0.0265	0.0481	CbGbCtD
Irbesartan—CYP2C9—Cholecalciferol—osteoporosis	0.026	0.0472	CbGbCtD
Irbesartan—CYP2D6—Cholecalciferol—osteoporosis	0.0238	0.0431	CbGbCtD
Irbesartan—CYP3A4—Ergocalciferol—osteoporosis	0.0235	0.0426	CbGbCtD
Irbesartan—CYP1A2—Estradiol—osteoporosis	0.0233	0.0422	CbGbCtD
Irbesartan—CYP2C9—Estradiol—osteoporosis	0.021	0.038	CbGbCtD
Irbesartan—CYP3A4—Raloxifene—osteoporosis	0.0196	0.0355	CbGbCtD
Irbesartan—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0189	0.0343	CbGbCtD
Irbesartan—CYP3A4—Cholecalciferol—osteoporosis	0.0151	0.0274	CbGbCtD
Irbesartan—CYP3A4—Conjugated Estrogens—osteoporosis	0.0139	0.0252	CbGbCtD
Irbesartan—CYP3A4—Estradiol—osteoporosis	0.0122	0.0221	CbGbCtD
Irbesartan—Losartan—ACE—osteoporosis	0.000221	1	CrCbGaD
Irbesartan—Paraesthesia—Risedronate—osteoporosis	0.000182	0.000597	CcSEcCtD
Irbesartan—Pruritus—Estropipate—osteoporosis	0.000181	0.000595	CcSEcCtD
Irbesartan—Discomfort—Zoledronate—osteoporosis	0.000181	0.000595	CcSEcCtD
Irbesartan—Asthenia—Alendronate—osteoporosis	0.000181	0.000594	CcSEcCtD
Irbesartan—Hypersensitivity—Ibandronate—osteoporosis	0.000181	0.000594	CcSEcCtD
Irbesartan—Cough—Conjugated Estrogens—osteoporosis	0.000181	0.000594	CcSEcCtD
Irbesartan—Dyspnoea—Risedronate—osteoporosis	0.000181	0.000593	CcSEcCtD
Irbesartan—Hypotension—Pamidronate—osteoporosis	0.00018	0.00059	CcSEcCtD
Irbesartan—Dry mouth—Zoledronate—osteoporosis	0.00018	0.000589	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00018	0.000589	CcSEcCtD
Irbesartan—Fatigue—Ethinyl Estradiol—osteoporosis	0.000179	0.000588	CcSEcCtD
Irbesartan—Pruritus—Alendronate—osteoporosis	0.000179	0.000586	CcSEcCtD
Irbesartan—Dyspepsia—Risedronate—osteoporosis	0.000178	0.000585	CcSEcCtD
Irbesartan—Tinnitus—Estradiol—osteoporosis	0.000178	0.000584	CcSEcCtD
Irbesartan—Constipation—Ethinyl Estradiol—osteoporosis	0.000178	0.000583	CcSEcCtD
Irbesartan—Hypersensitivity—Calcitriol—osteoporosis	0.000177	0.000582	CcSEcCtD
Irbesartan—Flushing—Estradiol—osteoporosis	0.000177	0.000581	CcSEcCtD
Irbesartan—Cardiac disorder—Estradiol—osteoporosis	0.000177	0.000581	CcSEcCtD
Irbesartan—Myalgia—Conjugated Estrogens—osteoporosis	0.000177	0.00058	CcSEcCtD
Irbesartan—Chest pain—Conjugated Estrogens—osteoporosis	0.000177	0.00058	CcSEcCtD
Irbesartan—Arthralgia—Conjugated Estrogens—osteoporosis	0.000177	0.00058	CcSEcCtD
Irbesartan—Asthenia—Ibandronate—osteoporosis	0.000177	0.000579	CcSEcCtD
Irbesartan—Anxiety—Conjugated Estrogens—osteoporosis	0.000176	0.000578	CcSEcCtD
Irbesartan—Nausea—Etidronic acid—osteoporosis	0.000176	0.000577	CcSEcCtD
Irbesartan—Anaphylactic shock—Zoledronate—osteoporosis	0.000176	0.000577	CcSEcCtD
Irbesartan—Oedema—Zoledronate—osteoporosis	0.000176	0.000577	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000176	0.000576	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000176	0.000576	CcSEcCtD
Irbesartan—Diarrhoea—Estropipate—osteoporosis	0.000176	0.000575	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Risedronate—osteoporosis	0.000175	0.000574	CcSEcCtD
Irbesartan—Infection—Zoledronate—osteoporosis	0.000175	0.000573	CcSEcCtD
Irbesartan—Fatigue—Risedronate—osteoporosis	0.000175	0.000573	CcSEcCtD
Irbesartan—Pruritus—Ibandronate—osteoporosis	0.000174	0.000571	CcSEcCtD
Irbesartan—Pain—Risedronate—osteoporosis	0.000173	0.000568	CcSEcCtD
Irbesartan—Constipation—Risedronate—osteoporosis	0.000173	0.000568	CcSEcCtD
Irbesartan—Angiopathy—Estradiol—osteoporosis	0.000173	0.000568	CcSEcCtD
Irbesartan—Shock—Zoledronate—osteoporosis	0.000173	0.000568	CcSEcCtD
Irbesartan—Paraesthesia—Pamidronate—osteoporosis	0.000173	0.000567	CcSEcCtD
Irbesartan—Diarrhoea—Alendronate—osteoporosis	0.000173	0.000567	CcSEcCtD
Irbesartan—Asthenia—Calcitriol—osteoporosis	0.000173	0.000566	CcSEcCtD
Irbesartan—Nervous system disorder—Zoledronate—osteoporosis	0.000173	0.000566	CcSEcCtD
Irbesartan—Immune system disorder—Estradiol—osteoporosis	0.000172	0.000565	CcSEcCtD
Irbesartan—Thrombocytopenia—Zoledronate—osteoporosis	0.000172	0.000565	CcSEcCtD
Irbesartan—Mediastinal disorder—Estradiol—osteoporosis	0.000172	0.000564	CcSEcCtD
Irbesartan—Dyspnoea—Pamidronate—osteoporosis	0.000172	0.000563	CcSEcCtD
Irbesartan—Tachycardia—Zoledronate—osteoporosis	0.000172	0.000563	CcSEcCtD
Irbesartan—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000171	0.000562	CcSEcCtD
Irbesartan—Chills—Estradiol—osteoporosis	0.000171	0.000562	CcSEcCtD
Irbesartan—Somnolence—Pamidronate—osteoporosis	0.000171	0.000562	CcSEcCtD
Irbesartan—Skin disorder—Zoledronate—osteoporosis	0.000171	0.000561	CcSEcCtD
Irbesartan—Pruritus—Calcitriol—osteoporosis	0.00017	0.000559	CcSEcCtD
Irbesartan—Hyperhidrosis—Zoledronate—osteoporosis	0.00017	0.000558	CcSEcCtD
Irbesartan—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00017	0.000557	CcSEcCtD
Irbesartan—Diarrhoea—Raloxifene—osteoporosis	0.00017	0.000557	CcSEcCtD
Irbesartan—Dyspepsia—Pamidronate—osteoporosis	0.00017	0.000556	CcSEcCtD
Irbesartan—Dizziness—Estropipate—osteoporosis	0.00017	0.000556	CcSEcCtD
Irbesartan—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00017	0.000556	CcSEcCtD
Irbesartan—Oedema—Conjugated Estrogens—osteoporosis	0.00017	0.000556	CcSEcCtD
Irbesartan—Infection—Conjugated Estrogens—osteoporosis	0.000168	0.000552	CcSEcCtD
Irbesartan—Diarrhoea—Ibandronate—osteoporosis	0.000168	0.000552	CcSEcCtD
Irbesartan—Anorexia—Zoledronate—osteoporosis	0.000168	0.00055	CcSEcCtD
Irbesartan—Decreased appetite—Pamidronate—osteoporosis	0.000168	0.000549	CcSEcCtD
Irbesartan—Dizziness—Alendronate—osteoporosis	0.000167	0.000548	CcSEcCtD
Irbesartan—Shock—Conjugated Estrogens—osteoporosis	0.000167	0.000547	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000166	0.000545	CcSEcCtD
Irbesartan—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000166	0.000545	CcSEcCtD
Irbesartan—Malnutrition—Estradiol—osteoporosis	0.000166	0.000545	CcSEcCtD
Irbesartan—Erythema—Estradiol—osteoporosis	0.000166	0.000545	CcSEcCtD
Irbesartan—Fatigue—Pamidronate—osteoporosis	0.000166	0.000545	CcSEcCtD
Irbesartan—Gastrointestinal pain—Risedronate—osteoporosis	0.000166	0.000544	CcSEcCtD
Irbesartan—Tachycardia—Conjugated Estrogens—osteoporosis	0.000165	0.000542	CcSEcCtD
Irbesartan—Urticaria—Ethinyl Estradiol—osteoporosis	0.000165	0.000542	CcSEcCtD
Irbesartan—Pain—Pamidronate—osteoporosis	0.000165	0.00054	CcSEcCtD
Irbesartan—Constipation—Pamidronate—osteoporosis	0.000165	0.00054	CcSEcCtD
Irbesartan—Diarrhoea—Calcitriol—osteoporosis	0.000165	0.00054	CcSEcCtD
Irbesartan—Skin disorder—Conjugated Estrogens—osteoporosis	0.000165	0.00054	CcSEcCtD
Irbesartan—Hypotension—Zoledronate—osteoporosis	0.000164	0.000539	CcSEcCtD
Irbesartan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000164	0.000539	CcSEcCtD
Irbesartan—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000164	0.000539	CcSEcCtD
Irbesartan—Dizziness—Raloxifene—osteoporosis	0.000164	0.000539	CcSEcCtD
Irbesartan—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000164	0.000537	CcSEcCtD
Irbesartan—Flatulence—Estradiol—osteoporosis	0.000164	0.000537	CcSEcCtD
Irbesartan—Tension—Estradiol—osteoporosis	0.000163	0.000535	CcSEcCtD
Irbesartan—Vomiting—Estropipate—osteoporosis	0.000163	0.000535	CcSEcCtD
Irbesartan—Dysgeusia—Estradiol—osteoporosis	0.000163	0.000534	CcSEcCtD
Irbesartan—Dizziness—Ibandronate—osteoporosis	0.000163	0.000533	CcSEcCtD
Irbesartan—Rash—Estropipate—osteoporosis	0.000162	0.00053	CcSEcCtD
Irbesartan—Dermatitis—Estropipate—osteoporosis	0.000162	0.00053	CcSEcCtD
Irbesartan—Anorexia—Conjugated Estrogens—osteoporosis	0.000162	0.00053	CcSEcCtD
Irbesartan—Nervousness—Estradiol—osteoporosis	0.000161	0.000529	CcSEcCtD
Irbesartan—Urticaria—Risedronate—osteoporosis	0.000161	0.000528	CcSEcCtD
Irbesartan—Headache—Estropipate—osteoporosis	0.000161	0.000527	CcSEcCtD
Irbesartan—Vomiting—Alendronate—osteoporosis	0.000161	0.000527	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00016	0.000526	CcSEcCtD
Irbesartan—Body temperature increased—Risedronate—osteoporosis	0.00016	0.000525	CcSEcCtD
Irbesartan—Abdominal pain—Risedronate—osteoporosis	0.00016	0.000525	CcSEcCtD
Irbesartan—Muscle spasms—Estradiol—osteoporosis	0.00016	0.000524	CcSEcCtD
Irbesartan—Rash—Alendronate—osteoporosis	0.000159	0.000522	CcSEcCtD
Irbesartan—Dermatitis—Alendronate—osteoporosis	0.000159	0.000522	CcSEcCtD
Irbesartan—Feeling abnormal—Pamidronate—osteoporosis	0.000159	0.000521	CcSEcCtD
Irbesartan—Hypotension—Conjugated Estrogens—osteoporosis	0.000158	0.000519	CcSEcCtD
Irbesartan—Headache—Alendronate—osteoporosis	0.000158	0.000519	CcSEcCtD
Irbesartan—Paraesthesia—Zoledronate—osteoporosis	0.000158	0.000518	CcSEcCtD
Irbesartan—Vomiting—Raloxifene—osteoporosis	0.000158	0.000518	CcSEcCtD
Irbesartan—Gastrointestinal pain—Pamidronate—osteoporosis	0.000158	0.000517	CcSEcCtD
Irbesartan—Dyspnoea—Zoledronate—osteoporosis	0.000157	0.000515	CcSEcCtD
Irbesartan—Rash—Raloxifene—osteoporosis	0.000157	0.000514	CcSEcCtD
Irbesartan—Dermatitis—Raloxifene—osteoporosis	0.000157	0.000513	CcSEcCtD
Irbesartan—Somnolence—Zoledronate—osteoporosis	0.000157	0.000513	CcSEcCtD
Irbesartan—Vomiting—Ibandronate—osteoporosis	0.000156	0.000513	CcSEcCtD
Irbesartan—Tremor—Estradiol—osteoporosis	0.000156	0.000511	CcSEcCtD
Irbesartan—Headache—Raloxifene—osteoporosis	0.000156	0.00051	CcSEcCtD
Irbesartan—Rash—Ibandronate—osteoporosis	0.000155	0.000509	CcSEcCtD
Irbesartan—Dermatitis—Ibandronate—osteoporosis	0.000155	0.000508	CcSEcCtD
Irbesartan—Dyspepsia—Zoledronate—osteoporosis	0.000155	0.000508	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000154	0.000506	CcSEcCtD
Irbesartan—Ill-defined disorder—Estradiol—osteoporosis	0.000154	0.000506	CcSEcCtD
Irbesartan—Headache—Ibandronate—osteoporosis	0.000154	0.000505	CcSEcCtD
Irbesartan—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000153	0.000502	CcSEcCtD
Irbesartan—Vomiting—Calcitriol—osteoporosis	0.000153	0.000502	CcSEcCtD
Irbesartan—Decreased appetite—Zoledronate—osteoporosis	0.000153	0.000502	CcSEcCtD
Irbesartan—Agitation—Estradiol—osteoporosis	0.000153	0.000501	CcSEcCtD
Irbesartan—Nausea—Estropipate—osteoporosis	0.000152	0.0005	CcSEcCtD
Irbesartan—Abdominal pain—Pamidronate—osteoporosis	0.000152	0.000499	CcSEcCtD
Irbesartan—Body temperature increased—Pamidronate—osteoporosis	0.000152	0.000499	CcSEcCtD
Irbesartan—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000152	0.000499	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000152	0.000498	CcSEcCtD
Irbesartan—Angioedema—Estradiol—osteoporosis	0.000152	0.000498	CcSEcCtD
Irbesartan—Rash—Calcitriol—osteoporosis	0.000152	0.000498	CcSEcCtD
Irbesartan—Fatigue—Zoledronate—osteoporosis	0.000152	0.000498	CcSEcCtD
Irbesartan—Dermatitis—Calcitriol—osteoporosis	0.000152	0.000497	CcSEcCtD
Irbesartan—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000151	0.000495	CcSEcCtD
Irbesartan—Headache—Calcitriol—osteoporosis	0.000151	0.000495	CcSEcCtD
Irbesartan—Somnolence—Conjugated Estrogens—osteoporosis	0.000151	0.000494	CcSEcCtD
Irbesartan—Pain—Zoledronate—osteoporosis	0.000151	0.000494	CcSEcCtD
Irbesartan—Constipation—Zoledronate—osteoporosis	0.000151	0.000494	CcSEcCtD
Irbesartan—Nausea—Alendronate—osteoporosis	0.00015	0.000492	CcSEcCtD
Irbesartan—Malaise—Estradiol—osteoporosis	0.00015	0.000491	CcSEcCtD
Irbesartan—Hypersensitivity—Risedronate—osteoporosis	0.000149	0.00049	CcSEcCtD
Irbesartan—Vertigo—Estradiol—osteoporosis	0.000149	0.00049	CcSEcCtD
Irbesartan—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000149	0.000489	CcSEcCtD
Irbesartan—Asthenia—Ethinyl Estradiol—osteoporosis	0.000149	0.000489	CcSEcCtD
Irbesartan—Syncope—Estradiol—osteoporosis	0.000149	0.000489	CcSEcCtD
Irbesartan—Nausea—Raloxifene—osteoporosis	0.000148	0.000484	CcSEcCtD
Irbesartan—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000147	0.000483	CcSEcCtD
Irbesartan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000147	0.000482	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000146	0.00048	CcSEcCtD
Irbesartan—Fatigue—Conjugated Estrogens—osteoporosis	0.000146	0.000479	CcSEcCtD
Irbesartan—Nausea—Ibandronate—osteoporosis	0.000146	0.000479	CcSEcCtD
Irbesartan—Loss of consciousness—Estradiol—osteoporosis	0.000146	0.000479	CcSEcCtD
Irbesartan—Asthenia—Risedronate—osteoporosis	0.000145	0.000477	CcSEcCtD
Irbesartan—Feeling abnormal—Zoledronate—osteoporosis	0.000145	0.000476	CcSEcCtD
Irbesartan—Cough—Estradiol—osteoporosis	0.000145	0.000476	CcSEcCtD
Irbesartan—Constipation—Conjugated Estrogens—osteoporosis	0.000145	0.000475	CcSEcCtD
Irbesartan—Pain—Conjugated Estrogens—osteoporosis	0.000145	0.000475	CcSEcCtD
Irbesartan—Gastrointestinal pain—Zoledronate—osteoporosis	0.000144	0.000472	CcSEcCtD
Irbesartan—Hypertension—Estradiol—osteoporosis	0.000144	0.000471	CcSEcCtD
Irbesartan—Pruritus—Risedronate—osteoporosis	0.000143	0.00047	CcSEcCtD
Irbesartan—Nausea—Calcitriol—osteoporosis	0.000143	0.000469	CcSEcCtD
Irbesartan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000142	0.000466	CcSEcCtD
Irbesartan—Hypersensitivity—Pamidronate—osteoporosis	0.000142	0.000466	CcSEcCtD
Irbesartan—Chest pain—Estradiol—osteoporosis	0.000142	0.000464	CcSEcCtD
Irbesartan—Arthralgia—Estradiol—osteoporosis	0.000142	0.000464	CcSEcCtD
Irbesartan—Myalgia—Estradiol—osteoporosis	0.000142	0.000464	CcSEcCtD
Irbesartan—Anxiety—Estradiol—osteoporosis	0.000141	0.000462	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000141	0.000461	CcSEcCtD
Irbesartan—Urticaria—Zoledronate—osteoporosis	0.00014	0.000458	CcSEcCtD
Irbesartan—Discomfort—Estradiol—osteoporosis	0.00014	0.000458	CcSEcCtD
Irbesartan—Abdominal pain—Zoledronate—osteoporosis	0.000139	0.000456	CcSEcCtD
Irbesartan—Body temperature increased—Zoledronate—osteoporosis	0.000139	0.000456	CcSEcCtD
Irbesartan—Diarrhoea—Risedronate—osteoporosis	0.000139	0.000455	CcSEcCtD
Irbesartan—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000139	0.000454	CcSEcCtD
Irbesartan—Dry mouth—Estradiol—osteoporosis	0.000138	0.000454	CcSEcCtD
Irbesartan—Asthenia—Pamidronate—osteoporosis	0.000138	0.000453	CcSEcCtD
Irbesartan—Dizziness—Ethinyl Estradiol—osteoporosis	0.000138	0.000451	CcSEcCtD
Irbesartan—Pruritus—Pamidronate—osteoporosis	0.000136	0.000447	CcSEcCtD
Irbesartan—Oedema—Estradiol—osteoporosis	0.000136	0.000445	CcSEcCtD
Irbesartan—Anaphylactic shock—Estradiol—osteoporosis	0.000136	0.000445	CcSEcCtD
Irbesartan—Infection—Estradiol—osteoporosis	0.000135	0.000442	CcSEcCtD
Irbesartan—Urticaria—Conjugated Estrogens—osteoporosis	0.000135	0.000441	CcSEcCtD
Irbesartan—Dizziness—Risedronate—osteoporosis	0.000134	0.00044	CcSEcCtD
Irbesartan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000134	0.000439	CcSEcCtD
Irbesartan—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000134	0.000439	CcSEcCtD
Irbesartan—Shock—Estradiol—osteoporosis	0.000133	0.000438	CcSEcCtD
Irbesartan—Nervous system disorder—Estradiol—osteoporosis	0.000133	0.000436	CcSEcCtD
Irbesartan—Tachycardia—Estradiol—osteoporosis	0.000132	0.000434	CcSEcCtD
Irbesartan—Vomiting—Ethinyl Estradiol—osteoporosis	0.000132	0.000433	CcSEcCtD
Irbesartan—Diarrhoea—Pamidronate—osteoporosis	0.000132	0.000432	CcSEcCtD
Irbesartan—Skin disorder—Estradiol—osteoporosis	0.000132	0.000432	CcSEcCtD
Irbesartan—Hyperhidrosis—Estradiol—osteoporosis	0.000131	0.00043	CcSEcCtD
Irbesartan—Rash—Ethinyl Estradiol—osteoporosis	0.000131	0.00043	CcSEcCtD
Irbesartan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000131	0.000429	CcSEcCtD
Irbesartan—Headache—Ethinyl Estradiol—osteoporosis	0.00013	0.000427	CcSEcCtD
Irbesartan—Hypersensitivity—Zoledronate—osteoporosis	0.00013	0.000425	CcSEcCtD
Irbesartan—Vomiting—Risedronate—osteoporosis	0.000129	0.000423	CcSEcCtD
Irbesartan—Rash—Risedronate—osteoporosis	0.000128	0.000419	CcSEcCtD
Irbesartan—Dermatitis—Risedronate—osteoporosis	0.000128	0.000419	CcSEcCtD
Irbesartan—Dizziness—Pamidronate—osteoporosis	0.000127	0.000418	CcSEcCtD
Irbesartan—Headache—Risedronate—osteoporosis	0.000127	0.000416	CcSEcCtD
Irbesartan—Asthenia—Zoledronate—osteoporosis	0.000126	0.000414	CcSEcCtD
Irbesartan—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000125	0.000409	CcSEcCtD
Irbesartan—Pruritus—Zoledronate—osteoporosis	0.000125	0.000408	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000124	0.000405	CcSEcCtD
Irbesartan—Nausea—Ethinyl Estradiol—osteoporosis	0.000124	0.000405	CcSEcCtD
Irbesartan—Vomiting—Pamidronate—osteoporosis	0.000123	0.000402	CcSEcCtD
Irbesartan—Paraesthesia—Estradiol—osteoporosis	0.000122	0.000399	CcSEcCtD
Irbesartan—Asthenia—Conjugated Estrogens—osteoporosis	0.000122	0.000399	CcSEcCtD
Irbesartan—Rash—Pamidronate—osteoporosis	0.000122	0.000398	CcSEcCtD
Irbesartan—Dermatitis—Pamidronate—osteoporosis	0.000121	0.000398	CcSEcCtD
Irbesartan—Dyspnoea—Estradiol—osteoporosis	0.000121	0.000397	CcSEcCtD
Irbesartan—Headache—Pamidronate—osteoporosis	0.000121	0.000396	CcSEcCtD
Irbesartan—Somnolence—Estradiol—osteoporosis	0.000121	0.000395	CcSEcCtD
Irbesartan—Diarrhoea—Zoledronate—osteoporosis	0.00012	0.000395	CcSEcCtD
Irbesartan—Nausea—Risedronate—osteoporosis	0.00012	0.000395	CcSEcCtD
Irbesartan—Pruritus—Conjugated Estrogens—osteoporosis	0.00012	0.000393	CcSEcCtD
Irbesartan—Dyspepsia—Estradiol—osteoporosis	0.000119	0.000392	CcSEcCtD
Irbesartan—Decreased appetite—Estradiol—osteoporosis	0.000118	0.000387	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Estradiol—osteoporosis	0.000117	0.000384	CcSEcCtD
Irbesartan—Fatigue—Estradiol—osteoporosis	0.000117	0.000383	CcSEcCtD
Irbesartan—Dizziness—Zoledronate—osteoporosis	0.000116	0.000382	CcSEcCtD
Irbesartan—Constipation—Estradiol—osteoporosis	0.000116	0.00038	CcSEcCtD
Irbesartan—Pain—Estradiol—osteoporosis	0.000116	0.00038	CcSEcCtD
Irbesartan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000116	0.00038	CcSEcCtD
Irbesartan—Nausea—Pamidronate—osteoporosis	0.000114	0.000375	CcSEcCtD
Irbesartan—Dizziness—Conjugated Estrogens—osteoporosis	0.000112	0.000367	CcSEcCtD
Irbesartan—Vomiting—Zoledronate—osteoporosis	0.000112	0.000367	CcSEcCtD
Irbesartan—Feeling abnormal—Estradiol—osteoporosis	0.000112	0.000367	CcSEcCtD
Irbesartan—Rash—Zoledronate—osteoporosis	0.000111	0.000364	CcSEcCtD
Irbesartan—Gastrointestinal pain—Estradiol—osteoporosis	0.000111	0.000364	CcSEcCtD
Irbesartan—Dermatitis—Zoledronate—osteoporosis	0.000111	0.000364	CcSEcCtD
Irbesartan—Headache—Zoledronate—osteoporosis	0.00011	0.000362	CcSEcCtD
Irbesartan—Vomiting—Conjugated Estrogens—osteoporosis	0.000108	0.000353	CcSEcCtD
Irbesartan—Urticaria—Estradiol—osteoporosis	0.000108	0.000353	CcSEcCtD
Irbesartan—Abdominal pain—Estradiol—osteoporosis	0.000107	0.000352	CcSEcCtD
Irbesartan—Body temperature increased—Estradiol—osteoporosis	0.000107	0.000352	CcSEcCtD
Irbesartan—Rash—Conjugated Estrogens—osteoporosis	0.000107	0.00035	CcSEcCtD
Irbesartan—Dermatitis—Conjugated Estrogens—osteoporosis	0.000107	0.00035	CcSEcCtD
Irbesartan—Headache—Conjugated Estrogens—osteoporosis	0.000106	0.000348	CcSEcCtD
Irbesartan—Nausea—Zoledronate—osteoporosis	0.000105	0.000343	CcSEcCtD
Irbesartan—Nausea—Conjugated Estrogens—osteoporosis	0.000101	0.00033	CcSEcCtD
Irbesartan—Hypersensitivity—Estradiol—osteoporosis	0.0001	0.000328	CcSEcCtD
Irbesartan—Asthenia—Estradiol—osteoporosis	9.73e-05	0.000319	CcSEcCtD
Irbesartan—Pruritus—Estradiol—osteoporosis	9.6e-05	0.000315	CcSEcCtD
Irbesartan—Diarrhoea—Estradiol—osteoporosis	9.28e-05	0.000304	CcSEcCtD
Irbesartan—Dizziness—Estradiol—osteoporosis	8.97e-05	0.000294	CcSEcCtD
Irbesartan—Vomiting—Estradiol—osteoporosis	8.63e-05	0.000283	CcSEcCtD
Irbesartan—Rash—Estradiol—osteoporosis	8.55e-05	0.00028	CcSEcCtD
Irbesartan—Dermatitis—Estradiol—osteoporosis	8.55e-05	0.00028	CcSEcCtD
Irbesartan—Headache—Estradiol—osteoporosis	8.5e-05	0.000279	CcSEcCtD
Irbesartan—Nausea—Estradiol—osteoporosis	8.06e-05	0.000264	CcSEcCtD
Irbesartan—CYP2C8—Biological oxidations—POMC—osteoporosis	4.95e-05	0.000345	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—FGA—osteoporosis	4.91e-05	0.000342	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TLN1—osteoporosis	4.9e-05	0.000342	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.9e-05	0.000341	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.9e-05	0.000341	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ENO1—osteoporosis	4.84e-05	0.000337	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—ADCY5—osteoporosis	4.83e-05	0.000337	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PSMA2—osteoporosis	4.77e-05	0.000333	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PSMA5—osteoporosis	4.77e-05	0.000333	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PKM—osteoporosis	4.67e-05	0.000325	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—FDPS—osteoporosis	4.67e-05	0.000325	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	4.66e-05	0.000325	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—KL—osteoporosis	4.65e-05	0.000324	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PTHLH—osteoporosis	4.56e-05	0.000318	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—BMP2—osteoporosis	4.56e-05	0.000318	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—POMC—osteoporosis	4.53e-05	0.000316	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—IL6—osteoporosis	4.48e-05	0.000312	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—FGB—osteoporosis	4.46e-05	0.000311	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PGLS—osteoporosis	4.42e-05	0.000308	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GPD2—osteoporosis	4.42e-05	0.000308	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6R—osteoporosis	4.42e-05	0.000308	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.42e-05	0.000308	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—IDH2—osteoporosis	4.41e-05	0.000308	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.36e-05	0.000304	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IRS1—osteoporosis	4.33e-05	0.000302	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PSMA2—osteoporosis	4.31e-05	0.0003	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PSMA5—osteoporosis	4.31e-05	0.0003	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—P4HB—osteoporosis	4.23e-05	0.000295	CbGpPWpGaD
Irbesartan—JUN—Immune System—KL—osteoporosis	4.21e-05	0.000294	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—IL6—osteoporosis	4.21e-05	0.000293	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.19e-05	0.000292	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.17e-05	0.00029	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP27A1—osteoporosis	4.15e-05	0.000289	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTH—osteoporosis	4.11e-05	0.000287	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6R—osteoporosis	4.07e-05	0.000283	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—POMC—osteoporosis	4.06e-05	0.000283	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ATIC—osteoporosis	4.05e-05	0.000282	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PNP—osteoporosis	4.05e-05	0.000282	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RAP1A—osteoporosis	4.04e-05	0.000282	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ACP5—osteoporosis	4.04e-05	0.000281	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—POMC—osteoporosis	4.03e-05	0.000281	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CALCA—osteoporosis	4.01e-05	0.00028	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CNR2—osteoporosis	4.01e-05	0.000279	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.99e-05	0.000278	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NFATC1—osteoporosis	3.94e-05	0.000275	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—POMC—osteoporosis	3.92e-05	0.000273	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DKK1—osteoporosis	3.91e-05	0.000273	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CYP19A1—osteoporosis	3.87e-05	0.00027	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PKM—osteoporosis	3.83e-05	0.000267	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—FDPS—osteoporosis	3.83e-05	0.000267	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—FDPS—osteoporosis	3.8e-05	0.000265	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PKM—osteoporosis	3.8e-05	0.000265	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—WNT1—osteoporosis	3.77e-05	0.000263	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—TPI1—osteoporosis	3.75e-05	0.000262	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FGA—osteoporosis	3.66e-05	0.000255	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—KL—osteoporosis	3.65e-05	0.000254	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ADCY5—osteoporosis	3.64e-05	0.000254	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GPD2—osteoporosis	3.63e-05	0.000253	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PGLS—osteoporosis	3.63e-05	0.000253	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PGLS—osteoporosis	3.6e-05	0.000251	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GPD2—osteoporosis	3.6e-05	0.000251	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.56e-05	0.000248	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—POMC—osteoporosis	3.56e-05	0.000248	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—P4HB—osteoporosis	3.53e-05	0.000246	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SPP1—osteoporosis	3.52e-05	0.000245	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6R—osteoporosis	3.47e-05	0.000242	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GAPDH—osteoporosis	3.46e-05	0.000241	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—POMC—osteoporosis	3.44e-05	0.00024	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—OXCT1—osteoporosis	3.44e-05	0.00024	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CA2—osteoporosis	3.44e-05	0.00024	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTHLH—osteoporosis	3.41e-05	0.000237	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—BMP2—osteoporosis	3.41e-05	0.000237	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—osteoporosis	3.39e-05	0.000236	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—RAP1A—osteoporosis	3.37e-05	0.000235	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MGLL—osteoporosis	3.35e-05	0.000234	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FGB—osteoporosis	3.33e-05	0.000232	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PNP—osteoporosis	3.32e-05	0.000232	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ATIC—osteoporosis	3.32e-05	0.000232	CbGpPWpGaD
Irbesartan—JUN—Immune System—AGER—osteoporosis	3.31e-05	0.000231	CbGpPWpGaD
Irbesartan—JUN—Immune System—ADCY5—osteoporosis	3.3e-05	0.00023	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ATIC—osteoporosis	3.29e-05	0.00023	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PNP—osteoporosis	3.29e-05	0.00023	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PKM—osteoporosis	3.25e-05	0.000226	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—FDPS—osteoporosis	3.25e-05	0.000226	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PSMA2—osteoporosis	3.22e-05	0.000224	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PSMA5—osteoporosis	3.22e-05	0.000224	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IRS2—osteoporosis	3.18e-05	0.000222	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ADCY5—osteoporosis	3.16e-05	0.00022	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.16e-05	0.00022	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GPX1—osteoporosis	3.15e-05	0.00022	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—LEP—osteoporosis	3.12e-05	0.000217	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PGLS—osteoporosis	3.08e-05	0.000214	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GPD2—osteoporosis	3.08e-05	0.000214	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CALCA—osteoporosis	3e-05	0.000209	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ESR1—osteoporosis	2.98e-05	0.000207	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.94e-05	0.000205	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—MTHFR—osteoporosis	2.91e-05	0.000203	CbGpPWpGaD
Irbesartan—JUN—Immune System—IRS2—osteoporosis	2.89e-05	0.000201	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ADCY5—osteoporosis	2.86e-05	0.000199	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—IDH2—osteoporosis	2.85e-05	0.000199	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CA2—osteoporosis	2.82e-05	0.000197	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—OXCT1—osteoporosis	2.82e-05	0.000197	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PNP—osteoporosis	2.81e-05	0.000196	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ATIC—osteoporosis	2.81e-05	0.000196	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—OXCT1—osteoporosis	2.8e-05	0.000195	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CA2—osteoporosis	2.8e-05	0.000195	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IRS1—osteoporosis	2.78e-05	0.000194	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SPP1—osteoporosis	2.76e-05	0.000193	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MGLL—osteoporosis	2.75e-05	0.000192	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MGLL—osteoporosis	2.73e-05	0.00019	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ENO1—osteoporosis	2.73e-05	0.00019	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—KL—osteoporosis	2.72e-05	0.00019	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PSMA2—osteoporosis	2.69e-05	0.000187	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PSMA5—osteoporosis	2.69e-05	0.000187	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.68e-05	0.000187	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—POMC—osteoporosis	2.68e-05	0.000187	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—POMC—osteoporosis	2.66e-05	0.000185	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6R—osteoporosis	2.61e-05	0.000182	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ACP5—osteoporosis	2.61e-05	0.000182	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IGF1—osteoporosis	2.57e-05	0.000179	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.57e-05	0.000179	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.57e-05	0.000179	CbGpPWpGaD
Irbesartan—JUN—Immune System—IRS1—osteoporosis	2.52e-05	0.000176	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PKM—osteoporosis	2.51e-05	0.000175	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—FDPS—osteoporosis	2.51e-05	0.000175	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IRS2—osteoporosis	2.5e-05	0.000174	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—LEP—osteoporosis	2.45e-05	0.00017	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TPI1—osteoporosis	2.42e-05	0.000169	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—OXCT1—osteoporosis	2.39e-05	0.000167	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CA2—osteoporosis	2.39e-05	0.000167	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PGLS—osteoporosis	2.37e-05	0.000166	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GPD2—osteoporosis	2.37e-05	0.000166	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6R—osteoporosis	2.37e-05	0.000165	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—IDH2—osteoporosis	2.34e-05	0.000163	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ESR1—osteoporosis	2.33e-05	0.000163	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MGLL—osteoporosis	2.33e-05	0.000163	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—POMC—osteoporosis	2.33e-05	0.000162	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—IDH2—osteoporosis	2.32e-05	0.000162	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—P4HB—osteoporosis	2.28e-05	0.000159	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GAPDH—osteoporosis	2.24e-05	0.000156	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.2e-05	0.000153	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.2e-05	0.000153	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.18e-05	0.000152	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IRS1—osteoporosis	2.18e-05	0.000152	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP19A1—osteoporosis	2.18e-05	0.000152	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—RAP1A—osteoporosis	2.18e-05	0.000152	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ATIC—osteoporosis	2.17e-05	0.000151	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PNP—osteoporosis	2.17e-05	0.000151	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ACP5—osteoporosis	2.14e-05	0.000149	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ADCY5—osteoporosis	2.13e-05	0.000149	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ACP5—osteoporosis	2.12e-05	0.000148	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—POMC—osteoporosis	2.1e-05	0.000146	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.1e-05	0.000146	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SPP1—osteoporosis	2.06e-05	0.000144	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6R—osteoporosis	2.05e-05	0.000143	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IGF1—osteoporosis	2.02e-05	0.000141	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TPI1—osteoporosis	1.99e-05	0.000139	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—IDH2—osteoporosis	1.98e-05	0.000138	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TPI1—osteoporosis	1.97e-05	0.000138	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—osteoporosis	1.97e-05	0.000137	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.9e-05	0.000132	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—P4HB—osteoporosis	1.87e-05	0.00013	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IRS2—osteoporosis	1.87e-05	0.00013	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.86e-05	0.00013	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—P4HB—osteoporosis	1.86e-05	0.000129	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CA2—osteoporosis	1.85e-05	0.000129	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—OXCT1—osteoporosis	1.85e-05	0.000129	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GAPDH—osteoporosis	1.84e-05	0.000128	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LEP—osteoporosis	1.83e-05	0.000127	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GAPDH—osteoporosis	1.82e-05	0.000127	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ACP5—osteoporosis	1.81e-05	0.000126	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—osteoporosis	1.81e-05	0.000126	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—osteoporosis	1.8e-05	0.000126	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MGLL—osteoporosis	1.8e-05	0.000125	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.79e-05	0.000125	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—RAP1A—osteoporosis	1.79e-05	0.000125	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ADCY5—osteoporosis	1.78e-05	0.000124	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GPX1—osteoporosis	1.78e-05	0.000124	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—RAP1A—osteoporosis	1.77e-05	0.000124	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ENO1—osteoporosis	1.76e-05	0.000123	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ESR1—osteoporosis	1.74e-05	0.000122	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PSMA5—osteoporosis	1.74e-05	0.000121	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PSMA2—osteoporosis	1.74e-05	0.000121	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TPI1—osteoporosis	1.69e-05	0.000118	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MTHFR—osteoporosis	1.64e-05	0.000114	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IRS1—osteoporosis	1.63e-05	0.000114	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—P4HB—osteoporosis	1.59e-05	0.00011	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—POMC—osteoporosis	1.57e-05	0.000109	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GAPDH—osteoporosis	1.56e-05	0.000108	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MYC—osteoporosis	1.55e-05	0.000108	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.55e-05	0.000108	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—osteoporosis	1.55e-05	0.000108	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—osteoporosis	1.54e-05	0.000108	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6R—osteoporosis	1.53e-05	0.000107	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—IDH2—osteoporosis	1.53e-05	0.000107	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—RAP1A—osteoporosis	1.52e-05	0.000106	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IGF1—osteoporosis	1.51e-05	0.000105	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ENO1—osteoporosis	1.45e-05	0.000101	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.44e-05	0.0001	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ENO1—osteoporosis	1.43e-05	9.99e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PSMA2—osteoporosis	1.42e-05	9.93e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PSMA5—osteoporosis	1.42e-05	9.93e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PSMA2—osteoporosis	1.41e-05	9.85e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PSMA5—osteoporosis	1.41e-05	9.85e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.41e-05	9.82e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ACP5—osteoporosis	1.4e-05	9.76e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.32e-05	9.21e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—POMC—osteoporosis	1.31e-05	9.13e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TPI1—osteoporosis	1.3e-05	9.07e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ENO1—osteoporosis	1.23e-05	8.54e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—P4HB—osteoporosis	1.22e-05	8.53e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MYC—osteoporosis	1.21e-05	8.46e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—osteoporosis	1.21e-05	8.44e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PSMA2—osteoporosis	1.21e-05	8.41e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PSMA5—osteoporosis	1.21e-05	8.41e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GAPDH—osteoporosis	1.2e-05	8.37e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—RAP1A—osteoporosis	1.17e-05	8.15e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—osteoporosis	1.16e-05	8.11e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.16e-05	8.06e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ADCY5—osteoporosis	1.15e-05	8.02e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GPX1—osteoporosis	1.15e-05	7.99e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.15e-05	7.99e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MTHFR—osteoporosis	1.06e-05	7.38e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—osteoporosis	1.05e-05	7.35e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP19A1—osteoporosis	9.79e-06	6.83e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ENO1—osteoporosis	9.45e-06	6.59e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADCY5—osteoporosis	9.45e-06	6.58e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GPX1—osteoporosis	9.41e-06	6.56e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADCY5—osteoporosis	9.36e-06	6.53e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GPX1—osteoporosis	9.33e-06	6.5e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PSMA5—osteoporosis	9.32e-06	6.49e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PSMA2—osteoporosis	9.32e-06	6.49e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—osteoporosis	9.13e-06	6.36e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MYC—osteoporosis	9.07e-06	6.32e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—osteoporosis	9.05e-06	6.31e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MTHFR—osteoporosis	8.69e-06	6.06e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MTHFR—osteoporosis	8.61e-06	6e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—POMC—osteoporosis	8.46e-06	5.9e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADCY5—osteoporosis	8e-06	5.58e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GPX1—osteoporosis	7.97e-06	5.56e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.56e-06	5.27e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MTHFR—osteoporosis	7.36e-06	5.13e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—POMC—osteoporosis	6.95e-06	4.84e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—POMC—osteoporosis	6.89e-06	4.8e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—osteoporosis	6.82e-06	4.75e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADCY5—osteoporosis	6.18e-06	4.3e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GPX1—osteoporosis	6.15e-06	4.29e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—POMC—osteoporosis	5.89e-06	4.1e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MTHFR—osteoporosis	5.68e-06	3.96e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—POMC—osteoporosis	4.54e-06	3.17e-05	CbGpPWpGaD
